Caregyn Ovules: Clinical Study on Vaginal Disorders

Home / Clinical Studies / Caregyn Ovules: Clinical Study on Vaginal Disorders

Clinically tested medical device for vaginal dryness, altered pH, and intimate discomfort

Vaginal dryness and altered vaginal pH are common issues affecting women of all ages, particularly during menopause, postpartum, or periods of physical and emotional stress. Typical symptoms include burning, itching, pain during intercourse, irritation, abnormal discharge, and emotional or sexual distress that can severely impair quality of life.

In this context, Gruppo FarmaImpresa has developed Caregyn Ovules, a vaginal medical device (FT.CE.111) whose efficacy has been confirmed by a clinical study.

Clinical Study on Caregyn Ovules: Significant Results with VSQ Questionnaire

To assess the efficacy of Caregyn Ovules, a clinical study was conducted on 19 women aged between 18 and 72 years, suffering from vaginal dryness and altered pH. The validated Vulvovaginal Symptoms Questionnaire (VSQ) was used before (T0) and after one week of treatment (T1).

The VSQ is a reliable clinical tool to measure physical symptoms, emotional impact, quality of life, and sexual activity. It is based on 16 items with dichotomous (yes/no) answers. Higher scores reflect more severe symptoms.

Clinical Results: Symptom Remission in Over 89% of Patients

The study showed a marked improvement after only one week of treatment with Caregyn Ovules:

  • The average VSQ score dropped from 5.11 to 0.16 points (Δ −4.95; p < 0.001), indicating a significant reduction in vaginal dryness and pH imbalance.
  • 89% of patients achieved complete remission of symptoms, with a VSQ score of 0.
  • All questionnaire items improved: itching, burning, pain, dryness, dyspareunia, impact on sexual life, emotions, and relationships.

The figure clearly shows the drastic reduction in total VSQ score after just 7 days of Caregyn Ovules use, confirming the speed and effectiveness of the treatment.

Who Can Benefit from Caregyn Ovules?

This medical device is indicated for:

  • Vaginal dryness due to menopause, breastfeeding, postpartum, or stress
  • Vaginal pH and microbiota alterations
  • Burning, itching, pain during intercourse
  • Dyspareunia and intimate discomfort
  • Support in pharmacological or antifungal treatments

It is suitable for women of all ages, including those of childbearing age, and fits perfectly within a complete gynecological treatment plan.

Why Choose Caregyn Ovules?

Caregyn Ovules is a clinically tested medical device backed by a clinical study. It stands out for:

  • 96.8% reduction in VSQ symptoms in 7 days
  • Complete remission in nearly 90% of cases
  • Proven effectiveness on physical, emotional, and sexual symptoms

Looking for a B2B-ready or private label solution?

We are certified manufacturers of medical devices, dietary supplements, and cosmetics. Caregyn Ovules is ready for market entry or private labeling, with full regulatory and clinical support.

We provide full Contract Development and Manufacturing (CDMO) services for:

  • Dietary supplements
  • Substance-based medical devices
  • Dermocosmetics

Our offerings include private label, out-licensing, and ready-to-market solutions, ensuring fast and efficient delivery. Every project is handled with a strong focus on quality, innovation, and regulatory compliance, supporting you through to market launch.

Share:

More Posts:

Send Us A Message

Subscribe to our Newsletter